Crossmark

Reduction of disease activity in rheumatoid arthritis by tocotrienol-rich fraction supplementation: a randomized, double-blind, placebo-controlled trial

Crossref DOI link: https://doi.org/10.1007/s00394-025-03742-6

Published Online: 2025-06-24

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zainal, Zaida https://orcid.org/0000-0002-4665-8620
Othman, Ahmad Z.

Rahim, Afiqah Abdul

Meganathan, Puvaneswari

Radhakrishnan, Ammu Kutty https://orcid.org/0000-0003-2638-907X
Funding

Funding for this research was provided by:

Malaysian Palm Oil Board (PD 201/15)
License Information

Text and Data Mining valid from 2025-06-24

Version of Record valid from 2025-06-24
More Information

Article History

Received: 10 January 2025

Accepted: 7 May 2025

First Online: 24 June 2025

Declarations

:

: All authors declare no conflict of interest.

Document is current

Any future updates will be listed below